...But Can't Attract U.S. Students

I would like to address a serious problem that has immediate and long-range consequences for biomedical education, the medical profession, and community health in general. It concerns, specifically, the alarming decrease in the number of young people seeking careers in biomedical research, medicine, and allied health professions. According to statistics compiled by the Association of American Medical Colleges, the number of college students taking the Medical College Aptitude Test (MCAT) has

Written byGeorge Pappas
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I would like to address a serious problem that has immediate and long-range consequences for biomedical education, the medical profession, and community health in general. It concerns, specifically, the alarming decrease in the number of young people seeking careers in biomedical research, medicine, and allied health professions.

According to statistics compiled by the Association of American Medical Colleges, the number of college students taking the Medical College Aptitude Test (MCAT) has decreased precipitously, and the mean score of those students taking the exam continues to decline. The situation for graduate students entering Ph.D. programs is even more grim. It is obvious that bright young people today are not interested in careers in the health field—either as practicing physicians, academicians, or research scientists.

Word is out that careers in the health field are not desirable, whether in terms of prestige, job, security, or financial reward. Why is this? One reason is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies